marcus evans is pleased to announce the participation of Synovo as a Sponsor at the Discovery Summit 2013 taking place at Le Méridien Beach Plaza, Monte-Carlo, Monaco 21-22 March 2013.

1. PRESS RELEASE (to be released Tuesday, 29 January 2013)
Synovo to join the Discovery Summit 2013 at Le Méridien Beach Plaza | Monte-Carlo | Monaco|
21-22 March 2013
marcus evans is pleased to announce the participation of Synovo as a Sponsor at the Discovery
Summit 2013 taking place at Le Méridien Beach Plaza | Monte-Carlo | Monaco 21-22 March 2013.
The Discovery Summit provides a unique and exclusive forum for global R&D professionals and drug
discovery sponsors to focus in an intimate environment on discussions around key new drivers
shaping discovery research and development today. More details about the Discovery Summit 2013
can be found here.
Synovo's main pharmacology activities are based on assays and models for the selection of drug
candidates with improved properties of Absorbtion, Disposition, Metabolism and Elimination (ADME
or DMPK). Synovo establishes these parameters using human derived cells, proteins and systems
wherever feasible to ensure the relevance of its data to use in man. Synovo is engaged in projects in
the fields of anti-inflammatory and immune suppressive drug optimisation on behalf of clients from
the pharmaceutical industry. Synovo is also working in partnership with public sector laboratories to
improve its systems and extend its technologies to protein and nucleic acid drugs. Based in
Tübingen, home of one of the best known Universities in Germany, Synovo GmbH benefits from
access to cutting edge technology, highly skilled staff and a magnificent location over looking the
Schwabian Alps. www.synovo.com
For further information on the Discovery Summit 2013 programme please contact
Ruth Abbott
Marketing PR & Communications Director
ruth.PRsummits@marcusevans.com
marcus evans